To be or not to be NKT: Natural killer T cells in the liver

Much of the hepatology literature to date has focused on the adaptive, antigen‐specific response mediated by classical T‐cell populations in both the protection and pathogenesis of liver disease. However, the liver is selectively enriched for cells representative of innate immunity, including natural killer T (NKT) cells. In particular, certain CD1d‐reactive T cells are present at much higher frequencies in the liver than in the peripheral blood. Although these cells have previously been defined mostly on the basis of phenotypic markers, recent emerging literature regarding NKT cell populations has revealed considerable functional complexity. This review summarizes the recent literature regarding NKT cells, which may have important roles in a variety of liver diseases. Although there is an abundance of literature on the phenotype, distribution, and function of these cells in mice, much less is known about them in human health or liver diseases. (HEPATOLOGY 2004;40:1033–1040.)

[1]  S. Tahir,et al.  Cutting Edge: A Major Fraction of Human Bone Marrow Lymphocytes Are Th2-Like CD1d-Reactive T Cells That Can Suppress Mixed Lymphocyte Responses1 , 2001, The Journal of Immunology.

[2]  S. Balk,et al.  Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997, The Journal of experimental medicine.

[3]  B. Graham,et al.  NK T Cells Contribute to Expansion of CD8+ T Cells and Amplification of Antiviral Immune Responses to Respiratory Syncytial Virus , 2002, Journal of Virology.

[4]  A. Diehl,et al.  Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. , 2002, Gastroenterology.

[5]  M. Ishigami,et al.  The roles of intrahepatic Vα14+ NK1.1+ T cells for liver injury induced by Salmonella infection in mice , 1999 .

[6]  V. Barnaba,et al.  Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis , 1998, European journal of immunology.

[7]  S. Snapper,et al.  Cd1-Reactive Natural Killer T Cells Are Required for Development of Systemic Tolerance through an Immune-Privileged Site , 1999, The Journal of experimental medicine.

[8]  G. Mayrhofer,et al.  Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. , 2003, Journal of immunology.

[9]  N. Afdhal,et al.  Hepatic CD1d Expression in Hepatitis C Virus Infection and Recognition by Resident Proinflammatory CD1d-Reactive T Cells1 , 2004, The Journal of Immunology.

[10]  D. Doherty,et al.  NKT Cells from Normal and Tumor-Bearing Human Livers Are Phenotypically and Functionally Distinct from Murine NKT Cells , 2003, The Journal of Immunology.

[11]  M. Taniguchi,et al.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. , 1997, Science.

[12]  M. Jackson,et al.  Peptide binding and presentation by mouse CD1. , 1995, Science.

[13]  A. Harris,et al.  NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells 1 , 2003, The Journal of Immunology.

[14]  R. Good,et al.  An NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Snapper,et al.  Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus. , 1999, Journal of immunology.

[16]  S. Tahir,et al.  CD1d‐reactive T‐cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus , 2001, Journal of leukocyte biology.

[17]  T. Kosaka,et al.  Association of CD8+ natural killer T cells in the liver with neonatal tolerance phenomenon. , 2002, Transplantation.

[18]  Hiroshi Sato,et al.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.

[19]  D. Pellicci,et al.  Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. , 2002, Blood.

[20]  P. Klenerman,et al.  Virus‐specific CD8+ T lymphocytes within the normal human liver , 2004, European journal of immunology.

[21]  J. Yewdell,et al.  CD1 recognition by mouse NK1+ T lymphocytes. , 1995, Science.

[22]  A. Diehl,et al.  Altered hepatic lymphocyte subpopulations in obesity‐related murine fatty livers: Potential mechanism for sensitization to liver damage , 2000, Hepatology.

[23]  F. Callea,et al.  Production of Profibrotic Cytokines by Invariant NKT Cells Characterizes Cirrhosis Progression in Chronic Viral Hepatitis1 , 2004, The Journal of Immunology.

[24]  L. Kaer,et al.  Critical contribution of liver natural killer T cells to a murine model of hepatitis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Takashi Yamamura,et al.  Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer Staining , 2002, The Journal of experimental medicine.

[26]  L. Lanier On guard—activating NK cell receptors , 2001, Nature Immunology.

[27]  S. Balk,et al.  Cutting Edge: Compartmentalization of Th1-Like Noninvariant CD1d-Reactive T Cells in Hepatitis C Virus-Infected Liver , 2002, The Journal of Immunology.

[28]  S. Balk,et al.  CD161 (NKR-P1A) Costimulation of CD1d-dependent Activation of Human T Cells Expressing Invariant Vα24JαQ T Cell Receptor α Chains , 1998, The Journal of experimental medicine.

[29]  J. Reimann,et al.  NKT Cells Provide Help for Dendritic Cell-Dependent Priming of MHC Class I-Restricted CD8+ T Cells In Vivo 1 , 2003, The Journal of Immunology.

[30]  M. Smyth,et al.  NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. , 2001, International immunology.

[31]  H. Watanabe,et al.  Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice , 1997, Immunology.

[32]  F. Leithäuser,et al.  Activating Immunity in the Liver. I. Liver Dendritic Cells (but Not Hepatocytes) Are Potent Activators of IFN-γ Release by Liver NKT Cells1 , 2001, The Journal of Immunology.

[33]  M. Kronenberg,et al.  Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. , 1998, Journal of immunology.

[34]  G. Giaccone,et al.  A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  S. Balk,et al.  Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain , 1993, The Journal of experimental medicine.

[36]  S. Ichimiya,et al.  Structural analysis of the rat homologue of CD1. Evidence for evolutionary conservation of the CD1D class and widespread transcription by rat cells. , 1994, Journal of immunology.

[37]  L. Kaer,et al.  Activation of hepatic NKT cells and subsequent liver injury following administration of α‐galactosylceramide , 2000, European journal of immunology.

[38]  T. Juji,et al.  Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. , 2004, Blood.

[39]  L. Kaer,et al.  NKT cells: what's in a name? , 2004, Nature Reviews Immunology.

[40]  L. Bry,et al.  Mechanism of CD1d-restricted natural killer T cell activation during microbial infection , 2003, Nature Immunology.

[41]  P. Klenerman,et al.  Frequency and Phenotype of Circulating Vα24/Vβ11 Double-Positive Natural Killer T Cells during Hepatitis C Virus Infection , 2003, Journal of Virology.

[42]  T. Juji,et al.  Therapeutic activation of Vα24^+Vβ11^+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity , 2004 .

[43]  T. Delovitch,et al.  Regulatory lymphocytes: Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity , 2003, Nature Reviews Immunology.

[44]  J. Trapani,et al.  Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells , 2000, The Journal of experimental medicine.

[45]  M. Kaplan,et al.  Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. , 2002, Gastroenterology.

[46]  D. Doherty,et al.  Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. , 2002, Journal of hepatology.

[47]  M. Brenner,et al.  Diverse TCRs recognize murine CD1. , 1999, Journal of immunology.

[48]  A. Wendel,et al.  Concanavalin A hepatotoxicity in mice: Tumor necrosis factor–mediated organ failure independent of caspase‐3–like protease activation , 1999, Hepatology.

[49]  M. Siomos,et al.  Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. , 2003, Immunity.

[50]  A. Dautry‐Varsat,et al.  Distinct Subsets of CD1d-restricted T Cells Recognize Self-antigens Loaded in Different Cellular Compartments , 1999, The Journal of experimental medicine.

[51]  G. Fantuzzi,et al.  Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. Huber,et al.  Role of CD1d in Coxsackievirus B3-Induced Myocarditis 1 , 2003, The Journal of Immunology.

[53]  H. Fujiwara,et al.  A Novel Function of Vα14+CD4+NKT Cells: Stimulation of IL-12 Production by Antigen-Presenting Cells in the Innate Immune System , 1999, The Journal of Immunology.

[54]  N. Hayashi,et al.  CD1d‐mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver , 2003, International journal of cancer.

[55]  R. Locksley,et al.  Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. , 2002, Immunity.

[56]  O. Shibolet,et al.  NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen‐pulsed dendritic cells , 2003, International journal of cancer.

[57]  G. Bubley,et al.  Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer1 , 2001, The Journal of Immunology.

[58]  O. Lantz,et al.  An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans , 1994, The Journal of experimental medicine.

[59]  M. Nozue,et al.  Impaired Proliferative Response of Vα24 NKT Cells from Cancer Patients Against α-Galactosylceramide1 , 2002, The Journal of Immunology.

[60]  L. Kaer,et al.  Cutting Edge: Critical Role of NK1+ T Cells in IL-12-Induced Immune Responses In Vivo , 1998, The Journal of Immunology.

[61]  K. Tsuneyama,et al.  Increased cd1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis , 1998, Hepatology.

[62]  L. Teyton,et al.  Distinct Functional Lineages of Human Vα24 Natural Killer T Cells , 2002, The Journal of experimental medicine.

[63]  A. Chott,et al.  Structure and Function of the CD1 Family of MHC‐like Cell Surface Proteins , 1995, Immunological reviews.

[64]  S. Seki,et al.  Mechanisms of the Antimetastatic Effect in the Liver and of the Hepatocyte Injury Induced by α-Galactosylceramide in Mice , 2001, The Journal of Immunology.

[65]  K. Tsuneyama,et al.  Accumulating CD57 + CD3 +  natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[66]  M. Neurath,et al.  Disruption of T helper 2-immune responses in Epstein–Barr virus-induced gene 3-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  A. Ohta,et al.  The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells , 1999, The Journal of experimental medicine.

[68]  S. Toyabe,et al.  Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. , 1997, Journal of immunology.

[69]  H. Fujiwara,et al.  Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[70]  Hiroshi Sato,et al.  Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .

[71]  A. Fersht,et al.  Human CD1d–glycolipid tetramers generated by in vitro oxidative refolding chromatography , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[72]  D. Doherty,et al.  The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. , 1999, Journal of immunology.

[73]  L. Teyton,et al.  In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers , 2000, The Journal of experimental medicine.

[74]  M. Alegre,et al.  Tissue distribution, regulation and intracellular localization of murine CD1 molecules. , 1998, Molecular immunology.

[75]  H. Nagawa,et al.  CD8+NKR‐P1A+ T cells preferentially accumulate in human liver , 1999, European journal of immunology.

[76]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[77]  河野 鉄 CD1d-restricted and TCR-mediated activation of V α14 NKT cells by glycosylceramides , 2000 .

[78]  R. Steinman,et al.  Activation of Natural Killer T Cells by -Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein , 2003 .

[79]  Michael B Brenner,et al.  CD1: antigen presentation and T cell function. , 2004, Annual review of immunology.

[80]  H. Macdonald,et al.  Selective Bystander Proliferation of Memory CD4+ and CD8+ T Cells Upon NK T or T Cell Activation , 2000, The Journal of Immunology.

[81]  P. Mannon,et al.  Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. , 2004, The Journal of clinical investigation.

[82]  M. Dhodapkar,et al.  A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma , 2003, The Journal of experimental medicine.

[83]  S. Kaufmann,et al.  Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta 2 and Th1 cytokines and ameliorates listeriosis in mice. , 1999, Journal of immunology.

[84]  K. Hatakeyama,et al.  Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation , 2000, Hepatology.

[85]  I. N. Crispe,et al.  Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.

[86]  M. Nozue,et al.  Impaired proliferative response of V alpha 24 NKT cells from cancer patients against alpha-galactosylceramide. , 2002, Journal of immunology.

[87]  R. Seeger,et al.  Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells1 , 2001, The Journal of Immunology.

[88]  H. Macdonald,et al.  Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. , 1999, Journal of immunology.

[89]  H. Fujiwara,et al.  A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. , 1999, Journal of immunology.

[90]  K. Tadokoro,et al.  Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner. , 1999, Human immunology.

[91]  S. Nuti,et al.  CD1d-restricted Help To B Cells By Human Invariant Natural Killer T Lymphocytes , 2003, The Journal of experimental medicine.

[92]  N. Fazilleau,et al.  Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[93]  D. Doherty,et al.  Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. , 1998, Journal of hepatology.

[94]  F. Chisari,et al.  Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo , 2000, The Journal of experimental medicine.

[95]  G. Fantuzzi,et al.  Leptin deficiency, not obesity, protects mice from Con A‐induced hepatitis , 2002, European journal of immunology.

[96]  S. Küsters,et al.  Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. , 1996, Gastroenterology.

[97]  H. S. Kim,et al.  The role of CD1d in the immune response against Listeria infection. , 2004, Cellular immunology.

[98]  Y. Koezuka,et al.  Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. , 1999, Journal of immunology.

[99]  Taniguchi,et al.  Differences in the Ligand Specificity between CD1d‐Restricted T Cells with Limited and Diverse T‐Cell Receptor Repertoire , 2000, Scandinavian journal of immunology.

[100]  H. Mochizuki,et al.  Decrease of CD56+T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma , 2000, Hepatology.

[101]  A. Tzakis,et al.  The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody. , 1998, Human immunology.

[102]  K. Tadokoro,et al.  Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner , 1999 .

[103]  S. Riddell,et al.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. , 2001, Nature immunology.

[104]  S. Porcelli,et al.  The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. , 1999, Annual review of immunology.

[105]  Y. Iwakura,et al.  Requirement for natural killer T (NKT) cells in the induction of allograft tolerance , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[106]  D. Pellicci,et al.  CD1d-Restricted NKT Cells: An Interstrain Comparison1 , 2001, The Journal of Immunology.

[107]  M. Kronenberg,et al.  CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution , 1998, The Journal of experimental medicine.

[108]  石上 雅敏 The roles of intrahepatic Vα14[+] NK1.1[+] T cells for liver injury induced by Salmonella infection in mice , 1999 .

[109]  M. Smyth,et al.  NKT cells are phenotypically and functionally diverse , 1999, European journal of immunology.